ClinicalTrials.govpublic full text
Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)
non-hodgkin's lymphoma, b-cell all, b-cell cll, cd19.car-cd28zeta, chimeric antigen receptor, hematopoietic stem cell transplant, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007875
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.